Results 71 to 80 of about 38,444 (194)
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi +13 more
wiley +1 more source
Síndrome de guillain-barré pós cirurgia bariátrica: relato de caso e revisão de literatura
Guillain-Barré Syndrome is an inflammatory polyneuroradiculopathy, being the most prevalent cause of acute flaccid paralysis, with an annual incidence of 1 to 2 cases per 100,000 people per year. It is clinically characterized, in its most common form,
Rodrigues, Helder Barbosa
core
Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort
Background: Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial
Levison, Lotte Sahin +5 more
core +1 more source
Background Guillain–Barre syndrome is an acquired inflammatory polyradiculoneuropathy that often follows gastrointestinal infection. A review of available literature revealed only few cases where Guillain–Barre syndrome developed after different types of
Yuliia Solodovnikova +3 more
doaj +1 more source
Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors
Long‐term sequelae after epidermal necrolysis are frequent, multiple and often severe. Cutaneous, ocular and psychological complications are more frequent, with significant socioeconomic impact. Cluster analysis identifies distinct patient profiles, highlighting the need for personalized multidisciplinary follow‐up.
Thanh Vy Nguyen +9 more
wiley +1 more source
Clinical implications of imlifidase interference in antibody screening and transfusion management
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani +2 more
wiley +1 more source
GUILLAIN-BARRÉ syndrome and hemolytic anemia associated with HTLV-1 infection
Male patient, 54 years old, with a history of Guillain-Barré syndrome, treated with Gabapentin. Four months before admission presents autoimmune hemolytic anemia, treated with prednisone.
Rául Vallejos Núñez +4 more
doaj +1 more source
Governance of Long‐Term Scientific Infrastructure: Public Value Does Not Protect Itself
Abstract Long‐term scientific infrastructure, including physical archives, monitoring networks, and place‐based research facilities, is frequently described as important but is rarely protected by enforceable governance. When administrative reorganization or budget pressure threatens such infrastructure, the scientific community typically responds with
A. Veltri
wiley +1 more source
Síndrome de Guillain-Barré [PDF]
En este artículo se lleva a cabo una revisión de conocimientos en materia de diagnóstico y tratamiento médico del síndrome de Guillain Barré o polirradiculoneuropatía inflamatoria desmielinizante ...
de Juan Frigola, Julián +1 more
core +2 more sources

